CAMBRIDGE, MA – Moderna, Inc. (NASDAQ:MRNA) announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged… Read More
New formulation showed non-inferiority to intravenous administration in fourth positive Phase 3 study in RYBREVANT® clinical program Longer overall survival, progression-free survival and duration of response shown with subcutaneous amivantamab;… Read More
British Columbia has been selected as the test bed for a potentially game-changing genomics project to improve kidney transplant outcomes across Canada in partnership with Canadian Blood Services — the… Read More
Alberta is maintaining global leadership in small molecule biology by expanding genomics-based services and tools for the health sector, agriculture and animal health sector, and other bio-based industries. CALGARY, AB… Read More
VANCOUVER, BC – Kapoose Creek Bio, a Vancouver-based biotechnology company leveraging AI for drug discovery from nature, announced the identification and advancement of two lead compounds with exciting potential in neurology, spanning… Read More
